SEC Form 4 · accession 0001140361-17-040605
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Oct 31, 2017
Accepted (ET)
Nov 1, 2017 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF2 | Oct 31, 2017 | M | 3,300 | $33.70 | A | 232,732 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Oct 31, 2017 | M | 3,300 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 3,300 | 0 | D |
Explanation of responses
- F1The transaction represents an exercise and hold of expiring options.
- F2Represents date options first became exercisable. Options vest 1/4 per year.